Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Shahedur Rahman

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

Graduate Student Researcher

1 pubs

  • Antineoplastic Agents
  • Macrocyclic Compounds
  • Histone Deacetylase Inhibitors
  • Carbocyanines
  • Humans
  • Indocyanine Green
  • Infrared Rays
  • Cell Line, Tumor
  • Nanomedicine
  • Nanoparticles
  • MCF-7 Cells

Biography and Research Information

OverviewAI-generated summary

Shahedur Rahman's research focuses on the development of nanomedicines for cancer therapy. His work, including a 2026 publication, investigates the use of macrocyclic histone deacetylase inhibitors integrated into near-infrared-responsive ionic nanomedicines. This approach aims to enhance the efficacy of cancer treatments by leveraging targeted drug delivery and response to external stimuli. Rahman collaborates with researchers at the University of Arkansas at Little Rock, including Nawab Ali, Monowar Hossain, and Adeolu Oluremi, as well as Mahfuzul Hassan from Philander Smith College, with whom he has co-authored publications. His scholarly output to date includes one publication.

Metrics

  • Publications: 1

Selected Publications

  • Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
    International Journal of Pharmaceutics DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

8 Collaborators 4 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics